Fathom Therapeutics
Uses quantum chemistry and AI to design novel drug molecules
$47MSeries A
Role not disclosedAV
Alexandria Venture Investments
Activity from announced rounds
Activity in this selectionOct 22, 2026 · AI · Jan 1, 2026
- Rounds participated in
- 4
- Confirmed lead rounds
- — 4 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $212M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionAlloy Therapeutics
Drug discovery platforms and integrated development services for biotechnology and pharmaceutical partners.
$40MSeries E
Role not disclosedTen63 Therapeutics
Develops AI-driven drug discovery platform for first- and best-in-class therapeutics
$45MStrategic
Role not disclosedProxima
Develops AI-driven drug discovery for proximity therapeutics
$80MUndisclosed
Role not disclosed